Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What else can 'Heparin' do?

U Lindahl1

  • 1Department of Medical Biochemistry and Microbiology, The Biomedical Centre, University of Uppsala, Uppsala, Sweden.

Haemostasis
|January 12, 2000
PubMed
Summary
This summary is machine-generated.

Heparin and heparan sulphate (HS) exert anticoagulant effects via specific molecular structures. HS proteoglycans regulate numerous physiological and pathological processes, influencing development and diseases like diabetes and Alzheimer's.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathophysiology of heparan sulphate: many diseases, few drugs.

Journal of internal medicine·2013
Same author

Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels.

British journal of pharmacology·2010
Same author

Biosynthesis of heparin and heparan sulfate.

Upsala journal of medical sciences·2010
Same author

Heparan sulphate requirement in platelet-derived growth factor B-mediated pericyte recruitment.

Biochemical Society transactions·2006
Same author

Structure and biological interactions of heparin and heparan sulfate.

Advances in carbohydrate chemistry and biochemistry·2002
Same author

Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharide.

Seminars in thrombosis and hemostasis·2001

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Glycobiology

Background:

  • Heparin and heparan sulphate (HS) are glycosaminoglycans with crucial biological roles.
  • A specific pentasaccharide sequence with a 3-O-sulphate group is key to heparin's anticoagulant activity.
  • HS proteoglycans exhibit significant structural variability due to regulated polymer modification.

Purpose of the Study:

  • To review the molecular basis of heparin and HS anticoagulant effects.
  • To outline the biosynthesis and structural diversity of HS.
  • To discuss the implications of HS-protein interactions and their role in physiological and pathological processes.

Main Methods:

  • Review of existing literature on heparin and HS.
  • Analysis of HS structural variability in mammalian organs.

Related Experiment Videos

  • Discussion of HS-protein binding mechanisms and their consequences.

    • Main Results:

    • Identification of a specific pentasaccharide sequence as critical for anticoagulant activity.
    • Demonstration of structural variability in HS preparations.
    • Evidence for HS proteoglycans influencing development and diseases like diabetes, amyloidosis, and Alzheimer's.

    Conclusions:

    • HS proteoglycans are vital regulators of numerous biological processes.
    • Structural modifications of HS play a significant role in health and disease.
    • HS chemistry offers potential for developing novel therapeutic strategies.